
Henry Schein is the master brand of Henry Schein, Inc. (Nasdaq: HSIC), a publicly traded healthcare distributor headquartered in Melville, New York. Founded in 1932, the brand covers dental, medical, and veterinary supplies plus practice software for office-based practitioners in more than 30 countries. The parent generates approximately $12.7 billion in annual revenue.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Henry Schein | Henry Schein, Inc. | Brand division |
Henry Schein founded the company with his Queens, New York pharmacy in 1932, selling dental and medical products to neighborhood practitioners.
The business stayed regional for decades until Stanley Bergman's leadership transformed it from the 1980s, taking it public in 1995 and consolidating the fragmented dental supply industry through steady acquisition.
Global expansion through the 2000s added European and Asian operations and built the medical and technology arms that now sit beside the dental core.
The software strategy consolidated into Henry Schein One, a joint venture that combined the company's practice-management assets into the Dentrix family of dental office platforms.
What does Henry Schein own?
Henry Schein owns its dental, medical, and technology distribution operations, private-label product brands, and the Henry Schein One practice software venture.
Is Henry Schein publicly traded?
Yes. It trades on the Nasdaq under ticker HSIC.
Who founded Henry Schein?
Henry Schein, a pharmacist who opened a Queens, New York store in 1932.
Who is the CEO of Henry Schein?
Stanley Bergman, CEO since 1989, one of the longest-serving public company chiefs.
What does Henry Schein sell?
Dental and medical consumables, equipment, vaccines, and practice software to office-based practitioners.
How much revenue does Henry Schein generate?
Approximately $12.7 billion annually.
Where is Henry Schein headquartered?
Melville, New York, USA, on Long Island.
Pricing transparency: The dental supply oligopoly draws periodic practitioner and regulator scrutiny over pricing, a category-wide issue rather than a brand-specific finding.
No major controversies are on record for the brand beyond routine industry litigation.
No direct competitors found in the same category. This could be because Henry Scheinoperates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by Henry Schein, Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike Henry Schein which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Owens & Minor
Healthcare supply brand of Owens & Minor, the Platinum Equity-owned hospital distribution and HALYARD products company.
Owens & Minor is privately owned, unlike Henry Schein which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023. Kimberly-Clark is acquiring Kenvue in a deal closed on November 2, 2026.
Tylenol is privately owned, unlike Henry Schein which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Henry Schein which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
Zocdoc is privately owned, unlike Henry Schein which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Availity
The largest real-time health information network in the US, owned by a consortium of major health insurers and Novo Holdings.
Availity is privately owned, unlike Henry Schein which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.